# To Investigate the Effects of AZD1981 on the QT Interval

> **NCT01265641** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 44 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AZD1981, 2000mg
- **DRUG:** AZD1981, 200mg
- **DRUG:** Moxifloxacin, 400mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01265641
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2011-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01265641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01265641, "To Investigate the Effects of AZD1981 on the QT Interval". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01265641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*